The Fullstack Investor
by Lin
v1.3
Explore
1
Watchlist
2
Themes
3
Live Feed
4
Dashboard
5
Earnings
6
TOols
Market Model
Start Here
Connect
Twitter
Login
L
Logout
X
Go Back
Company or ticker...
Apogee develops long-acting biologic drugs for inflammatory and immune diseases.
Ticker
M. Cap
PS
PE
YTD
10MA
20MA
50MA
200MA
APGE
10.0B
0.0
n/a
74.50%
Key Facts
Join Now
